Leading Medical Company Receives FDA Clearance For Obesity Drug Candidate

Groundbreaking Progress in Obesity Treatment: NeuroBo Pharmaceuticals Receives FDA Clearance for Clinical Trial of DA-1726.

Disclaimer: This article is for informational purposes only and should not be taken as medical advice. Always consult with a healthcare professional before starting any new medication or treatment.

In a significant milestone for obesity treatment, NeuroBo Pharmaceuticals, a leading pharmaceutical company, has received FDA clearance to commence a Phase 1 …